Piramal Pharma Limited has reported consolidated financial results for the period ended June 30, 2025.

Piramal Pharma has posted net loss of Rs. 81.70 crores for the period ended June 30, 2025 as against net profit of Rs. 153.50 crores for the period ended March 31, 2025. The company posted net profit loss of Rs. 88.64 crores for the period ended June 30, 2024.

Piramal Pharma has reported total income of Rs. 1,992.11 crores during the period ended June 30, 2025 as compared to Rs. 2,796.10 crores during the period ended March 31, 2025. The company reported total income of Rs. 1,970.68 crores during the period ended June 30, 2024.